Delic Corp (DELC.C) announced that their wholly-owned subsidiary, DELIC Labs, has entered into a partnership agreement with Agilent. Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise,…
Delic
Delic Holdings (DELC.C) announced their recently acquired entity Complex Biotech Discovery Ventures (CBDV) has been rebranded as Delic Labs. Delic Labs is a federally authorized psilocybin and cannabis research…
On May 27, Delic Holdings (DELC.C) announced they have acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures (CBDV), completing their acquisition…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Venture (CBDV), has closed their previously-announced non-brokered private placement. The private placement consists of 11,441,189 CBDV Subscription Receipts…
Delic Holdings (DELC.C) announced that their acquisition target, Ketamine Infusion Centers (KIC), proposed an acquisition of two additional licensed ketamine clinics in Arizona. Back in February, Delic signed a…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Ventures (CBDV), has hired Dr. Eric Janusson as their Lead Chemist. Dr. Eric Janusson is an analytical organometallic…